Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
|
Investment Grade:
|
|
Comments(0)
|
(0)
|
(0)
|
Ranking History
Headlines
- Value Insight - November 2008
Nov 29, 2008 11:50 AM
- Stock Picks For Healthy Returns
Nov 25, 2008 10:19 AM
- Generics Giant Teva Shines
Nov 09, 2008 01:53 PM
- Earnings Review – Oct 31
Oct 31, 2008 12:29 PM
- The Week in Review: Broad Themes And Deals
Oct 25, 2008 04:56 PM
- Retail Survey Report: Footlocker, Blackberry, Sony Reader
Oct 23, 2008 10:32 AM
- Outbreak Of CRO And Big Pharma Activity In China
Oct 22, 2008 07:21 PM
- Johnson & Johnson: Is it Too Late?
Oct 15, 2008 08:44 AM
- Eli Lilly Sinks After Hours On Effient Delay
Sep 28, 2008 04:41 PM
- Buffett’s Goldman Deal Has Big Benefits, But What Else Is Berkshire Up To?
Sep 25, 2008 04:46 PM
- Welvista Announces Partnering with sanofi-aventis U.S. to Provide Medication at No Cost to the Uninsured
Dec 01, 2008 12:34 PM
- Perrigo Acknowledges Settlement of NASACORT(R) AQ Nasal Spray Patent Litigation
Nov 19, 2008 08:02 AM
- Russia Chooses Inactivated Polio Vaccine from Sanofi Pasteur for Primary Immunization of all Infants
Nov 12, 2008 04:35 AM
- Dronedarone (Multaq(R)) Reduced the Incidence and Duration of Hospitalization in Patients with Atrial Fibrillation
Nov 11, 2008 10:30 AM
- Rationale and Design of CURRENT-OASIS 7 Study Published in American Heart Journal
Nov 06, 2008 02:01 AM
- Sanofi-aventis Q3 2008 Adjusted EPS Excluding Selected Items(1):
Oct 31, 2008 01:32 PM
- FDA Approves Rapid-Acting Insulin Apidra(R) for Treatment of Children with Diabetes
Oct 29, 2008 09:45 AM
- High-Dose Influenza Vaccine Shows Increased Immune Response Among Adults 65 Years of Age and Older
Oct 27, 2008 09:01 AM
- High-Dose Influenza Vaccine Shows Increased Immune Response Among Adults 65 Years of Age and Older
Oct 26, 2008 11:15 AM
- Diabetes 'Champions' Share their Stories through Circle of Champions Campaign
Oct 16, 2008 08:01 AM
Analyst Ratings
|
|
Share Performance
|
Period
|
SNY
|
Compare to S&P
|
| YTD |
-41.44 %
|
-0.01 %
|
| 4 Weeks |
-14.58 %
|
1.13 %
|
| 12 Weeks |
-18.89 %
|
25.98 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 2.88 %
|
|
EPS Growth in Last Year: 8.08 %
|
|
Sales Growth in Last Quarter: -2.69 %
|
|
Sales Growth in Last Quarter: -0.05 %
|
|
|
